Board Meetings for EXPLEOSOL
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| EXPLEOSOL | Expleo Solutions Limited | 06 May 2019 | Financial Results | Dear Sir/Madam,This is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Monday, May 6, 2019, inter-alia,1. To consider and approve the Audited Standalone Financial Results of the Company for the quarter and year ended March 31, 2019.2. To consider and approve the Audited Consolidated Financial Results of the Company for the quarter and year ended March 31, 2019.You are requested to take the above on record and oblige.Thanking you, | |
| EXPLEOSOL | Expleo Solutions Limited | 29 Mar 2019 | Buyback | Dear Sir,This is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Friday, March 29, 2019, inter-alia, to consider and approve the following:1. Finalisation of Buyback Price2. Fixing of Record Date for Buyback You are requested to take the above on record and oblige. | |
| EXPLEOSOL | Expleo Solutions Limited | 31 Jan 2019 | Buyback | Further to our letter no. SEC/SE/176/18-19 & SEC/SE/177/18-19 dated January 24, 2019, intimating the Stock Exchanges regarding the Board Meeting to be held on Thursday, January 31, 2019, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2018, we also wish to inform you that pursuant to Regulation 29 and other applicable regulations of the Listing Regulations, notice is hereby given that a meeting of the Board of Directors of the Company as intimated earlier, to be held on Thursday, January 31, 2019 will also inter-alia, consider the proposal for buy-back of fully paid-up equity shares of the Company. The outcome of the meeting of the Board of Directors of the Company will be disseminated to the stock exchanges after conclusion of the same on January 31, 2019, in accordance with Regulation 30 of the Listing Regulations. We request you to kindly take the aforesaid information on record in terms of Regulations 29(1)(b) and 29(2) of the Listing Regulations.The information contained in this notice is also available on the Company��s corporate website, (www.sqs-bfsi.com), on the website of National Stock Exchange of India Limited (www.nseindia.com) and BSE Limited (www.bseindia.com).Kindly take the above on record. | |
| EXPLEOSOL | Expleo Solutions Limited | 31 Jan 2019 | Financial Results | Dear Sir/Madam,This is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Thursday, January 31, 2019, inter-alia,1. To consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2018.2. To consider and approve the Unaudited Consolidated Financial Results of the Company for the quarter ended December 31, 2018.Further, in accordance with the Code of Conduct to regulate, monitor and report trading by insiders of the Company, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in shares of the Company will remain closed from Thursday, January 24, 2019 and shall reopen on Monday, February 04, 2019 for Promoters, Directors, Officers and Designated Persons of the Company.You are requested to take the above on record and oblige.Thanking you, | |
| EXPLEOSOL | Expleo Solutions Limited | 25 Oct 2018 | Financial Results | Dear Sir/Madam,This is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Thursday, October 25, 2018, inter-alia,1. To consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2018.2. To consider and approve the Unaudited Consolidated Financial Results of the Company for the quarter ended September 30, 2018.You are requested to take the above on record and oblige.Thanking you, | |
| EXPLEOSOL | Expleo Solutions Limited | 26 Jul 2018 | Financial Results | Dear Sir/Madam,This is to inform you that the meeting of Board of Directors of the Company is scheduled to be held on Thursday, July 26, 2018, inter-alia,1. To consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2018.2. To consider and approve the Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2018.We also wish to inform you that the Company has received a Resignation Letter dated July 17, 2018 from Mr. K. Ramaseshan resigning from the post of Additional Director, Executive Director and Chief Financial Officer (Key Managerial Personnel). The resignation letter received by the Company will be placed before the Board Meeting scheduled to be held on Thursday, July 26, 2018 for their consideration. Further, in accordance with the Code of Conduct to regulate, monitor and report trading by insiders of the Company, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in shares of the Company will remain closed from Wednesday, July 18, 2018 and shall reopen on Monday, July 30, 2018 for Promoters, Directors, Officers and Designated Persons of the Company.You are requested to take the above on record and oblige.Thanking you, | |
| EXPLEOSOL | Expleo Solutions Limited | 04 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend, if any | |
| EXPLEOSOL | Expleo Solutions Limited | 25 Jan 2018 | Results | Inter-alia, 1. To consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2017 2. To consider and approve the Unaudited Consolidated Financial Results of the Company for the quarter ended December 31, 2017. | |
| EXPLEOSOL | Expleo Solutions Limited | 26 Oct 2017 | Results/Dividend | Inter-alia, 1. To consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2017 2. To consider and approve the Unaudited Consolidated Financial Results of the Company for the quarter ended September 30, 2017 3. To Consider Interim Dividend, if any, for the Financial Year 2017-18. | |
| EXPLEOSOL | Expleo Solutions Limited | 27 Jul 2017 | Results | inter-alia, (1). To consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017 .(2). To consider and approve the Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2017. | |
| EXPLEOSOL | Expleo Solutions Limited | 27 Apr 2017 | Results/Dividend | inter-alia, 1. To consider and approve the Audited Financial Results of the company for the quarter and year ending March 31, 2017 2. To consider and approve the Audited Consolidated Financial Results of the Company for the quarter and year ending March 31, 2017 3. To consider recommendation of Final Dividend, if any, for the financial year ending March 31, 2017. Further, in accordance with the Code of Conduct to regulate, monitor and report trading by insiders of the Company, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in shares of the Company will remain closed from April 20, 2017 and shall reopen on May 02, 2017 for Promoters, Directors, Officers and Designated Persons of the Company. | |
| EXPLEOSOL | Expleo Solutions Limited | 02 Feb 2017 | Results | Inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter ending December 31, 2016. | |
| EXPLEOSOL | Expleo Solutions Limited | 20 Oct 2016 | Results/Dividend | inter-alia: (1). To consider and approve the Unaudited Financial Results of the Company for the quarter ending September 30, 2016.(2). To Consider Interim Dividend, if any, for the Financial Year 2016-17. | |
| EXPLEOSOL | Expleo Solutions Limited | 28 Jul 2016 | Results | inter-alia: (1). To consider and approve the Unaudited Financial Results of the Company for the quarter ending June 30, 2016(2). To consider and approve the Unaudited Consolidated Financial Results of the Company for the quarter ending June 30, 2016. | |
| EXPLEOSOL | Expleo Solutions Limited | 28 Apr 2016 | Results/Dividend | Inter-alia, 1. To consider and approve the Audited Financial Results of the company for the quarter and year ending March 31, 20162. To consider recommendation of Final Dividend, if any, for the financial year ending March 31, 2016. |